Share Price and Basic Stock Data
Last Updated: October 18, 2025, 5:59 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
MRF Ltd, a prominent player in the Tyres & Tubes industry, reported a stock price of ₹1,56,885 and a market capitalization of ₹66,629 Cr. The company’s sales have shown a steady growth trajectory, with quarterly sales rising from ₹5,696 Cr in June 2022 to ₹6,440 Cr in June 2023. This upward trend continued, with sales reaching ₹6,349 Cr in March 2024 and projected to further increase to ₹7,676 Cr by June 2025. The annual sales figures corroborate this growth, standing at ₹23,008 Cr for FY 2023 and expected to reach ₹28,152 Cr in FY 2025. MRF’s operational profitability is reflected in its operating profit margin (OPM), which rose from 9% in June 2022 to a peak of 19% in September 2023, indicating improved efficiency and cost management. This consistent revenue growth positions MRF favorably within a competitive sector, suggesting robust demand for its products. The resilience in sales amidst fluctuating market conditions highlights MRF’s strategic operational decisions.
Profitability and Efficiency Metrics
MRF Ltd has demonstrated solid profitability metrics, as evidenced by its net profit, which stood at ₹1,869 Cr for FY 2025, up from ₹769 Cr in FY 2023. The company’s earnings per share (EPS) reflected this growth, increasing from ₹1,813.04 in FY 2023 to ₹4,407.54 in FY 2025. The return on equity (ROE) was reported at 10.6%, while the return on capital employed (ROCE) was slightly higher at 13.6%, indicating effective utilization of shareholders’ funds and capital. The interest coverage ratio (ICR) at 12.95x further illustrates MRF’s strong ability to meet its interest obligations, showcasing financial health. Additionally, the cash conversion cycle (CCC) stood at 101 days, which, while slightly extended, indicates a manageable level of operational efficiency. MRF’s ability to sustain these profitability ratios amidst rising expenses, which have also increased from ₹5,203 Cr in June 2022 to ₹6,604 Cr in June 2025, underscores its operational resilience.
Balance Sheet Strength and Financial Ratios
MRF’s financial position is robust, with total reserves amounting to ₹18,484 Cr against borrowings of ₹3,771 Cr, reflecting a healthy reserve-to-borrowing ratio. This translates to a low total debt-to-equity ratio of 0.12, indicating a conservative approach to leverage, which is beneficial in times of economic uncertainty. The company reported a current ratio of 1.37 and a quick ratio of 0.78, suggesting adequate liquidity to meet short-term obligations, although the quick ratio may raise some concerns regarding immediate liquidity. The price-to-book value (P/BV) stood at 3.38x, indicating that the market values the company’s equity significantly higher than its book value, a sign of investor confidence. MRF’s asset turnover ratio of 0.98% indicates efficient use of assets in generating sales. These financial ratios collectively reinforce MRF’s strong balance sheet and its ability to navigate market challenges effectively.
Shareholding Pattern and Investor Confidence
The shareholding structure of MRF Ltd reveals a diverse ownership base, with promoters holding 27.78% of the shares, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold 18.67% and 11.66%, respectively. Public ownership accounts for 41.88%, indicating a broad base of retail investors. The number of shareholders increased to 50,253 as of June 2025, reflecting growing investor interest in the company. While promoter holdings have remained stable, FIIs showed a slight decline from 19.75% in March 2024 to 17.54% in March 2025, suggesting potential concerns regarding foreign investment sentiment. The stability in promoter holdings combined with a diverse investor base bodes well for MRF’s governance and strategic direction, instilling confidence among stakeholders amid a competitive landscape.
Outlook, Risks, and Final Insight
If margins sustain their current levels, MRF is well-positioned to leverage its market leadership and operational efficiencies for continued growth. However, risks include potential volatility in raw material prices, which could pressure margins, and increasing competition in the tyre sector. Additionally, fluctuations in consumer demand and economic conditions may impact sales. The company’s ability to innovate and adapt to changing market dynamics will be crucial in maintaining its competitive edge. Overall, MRF’s strong financial metrics, coupled with a solid balance sheet, provide a foundation for navigating these risks while pursuing growth opportunities in the tyre industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of MRF Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| MRF Ltd | 66,136 Cr. | 1,55,940 | 1,60,150/1,00,500 | 36.8 | 43,594 | 0.15 % | 13.6 % | 10.6 % | 10.0 |
| Innovative Tyres & Tubes Ltd | 89.1 Cr. | 89.1 | 152/18.6 | 16.3 | 0.00 % | 49.5 % | % | 10.0 | |
| Industry Average | 66,136.00 Cr | 78,014.55 | 36.80 | 21,805.15 | 0.08% | 31.55% | 10.60% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,696 | 5,826 | 5,645 | 5,842 | 6,440 | 6,217 | 6,162 | 6,349 | 7,196 | 6,881 | 7,001 | 7,075 | 7,676 |
| Expenses | 5,203 | 5,346 | 5,083 | 4,988 | 5,310 | 5,060 | 5,108 | 5,437 | 6,037 | 5,870 | 6,166 | 5,996 | 6,604 |
| Operating Profit | 493 | 481 | 562 | 854 | 1,130 | 1,157 | 1,055 | 912 | 1,160 | 1,011 | 835 | 1,079 | 1,071 |
| OPM % | 9% | 8% | 10% | 15% | 18% | 19% | 17% | 14% | 16% | 15% | 12% | 15% | 14% |
| Other Income | 34 | 77 | 71 | 70 | 75 | 71 | 78 | 94 | 84 | 113 | 98 | 113 | 126 |
| Interest | 66 | 75 | 86 | 92 | 84 | 86 | 90 | 93 | 85 | 84 | 94 | 98 | 98 |
| Depreciation | 298 | 309 | 316 | 330 | 333 | 351 | 360 | 385 | 396 | 410 | 415 | 433 | 429 |
| Profit before tax | 164 | 174 | 231 | 501 | 787 | 791 | 682 | 527 | 763 | 631 | 424 | 661 | 670 |
| Tax % | 25% | 25% | 24% | 32% | 25% | 26% | 25% | 25% | 25% | 25% | 26% | 22% | 25% |
| Net Profit | 124 | 130 | 175 | 341 | 589 | 587 | 510 | 396 | 571 | 471 | 315 | 512 | 500 |
| EPS in Rs | 291.43 | 306.19 | 412.23 | 803.19 | 1,388.20 | 1,383.27 | 1,201.83 | 933.96 | 1,346.40 | 1,109.85 | 743.79 | 1,207.49 | 1,180.05 |
Last Updated: August 20, 2025, 6:45 am
Below is a detailed analysis of the quarterly data for MRF Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 7,676.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,075.00 Cr. (Mar 2025) to 7,676.00 Cr., marking an increase of 601.00 Cr..
- For Expenses, as of Jun 2025, the value is 6,604.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,996.00 Cr. (Mar 2025) to 6,604.00 Cr., marking an increase of 608.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 1,071.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,079.00 Cr. (Mar 2025) to 1,071.00 Cr., marking a decrease of 8.00 Cr..
- For OPM %, as of Jun 2025, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Mar 2025) to 14.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 113.00 Cr. (Mar 2025) to 126.00 Cr., marking an increase of 13.00 Cr..
- For Interest, as of Jun 2025, the value is 98.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 98.00 Cr..
- For Depreciation, as of Jun 2025, the value is 429.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 433.00 Cr. (Mar 2025) to 429.00 Cr., marking a decrease of 4.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 670.00 Cr.. The value appears strong and on an upward trend. It has increased from 661.00 Cr. (Mar 2025) to 670.00 Cr., marking an increase of 9.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Mar 2025) to 25.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 512.00 Cr. (Mar 2025) to 500.00 Cr., marking a decrease of 12.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1,180.05. The value appears to be declining and may need further review. It has decreased from 1,207.49 (Mar 2025) to 1,180.05, marking a decrease of 27.44.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:49 am
| Metric | Sep 2013 | Sep 2014 | Mar 2016n n 18m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12,248 | 13,329 | 20,179 | 13,412 | 14,954 | 16,062 | 16,237 | 16,162 | 19,317 | 23,008 | 25,169 | 28,152 | 28,632 |
| Expenses | 10,468 | 11,384 | 15,743 | 10,763 | 12,665 | 13,744 | 13,855 | 13,208 | 17,256 | 20,604 | 20,896 | 24,058 | 24,636 |
| Operating Profit | 1,780 | 1,945 | 4,437 | 2,649 | 2,288 | 2,317 | 2,382 | 2,954 | 2,061 | 2,404 | 4,272 | 4,095 | 3,996 |
| OPM % | 15% | 15% | 22% | 20% | 15% | 14% | 15% | 18% | 11% | 10% | 17% | 15% | 14% |
| Other Income | 25 | 63 | 317 | 327 | 330 | 416 | 335 | 205 | 315 | 245 | 306 | 406 | 450 |
| Interest | 196 | 232 | 361 | 257 | 259 | 273 | 301 | 282 | 263 | 326 | 361 | 368 | 374 |
| Depreciation | 374 | 424 | 737 | 611 | 707 | 808 | 982 | 1,141 | 1,205 | 1,253 | 1,430 | 1,654 | 1,686 |
| Profit before tax | 1,235 | 1,353 | 3,656 | 2,109 | 1,653 | 1,652 | 1,434 | 1,737 | 908 | 1,070 | 2,787 | 2,479 | 2,387 |
| Tax % | 35% | 33% | 31% | 30% | 32% | 32% | 1% | 26% | 26% | 28% | 25% | 25% | |
| Net Profit | 809 | 908 | 2,509 | 1,486 | 1,132 | 1,131 | 1,423 | 1,277 | 669 | 769 | 2,081 | 1,869 | 1,799 |
| EPS in Rs | 1,906.58 | 2,141.71 | 5,916.93 | 3,504.33 | 2,668.20 | 2,665.82 | 3,354.22 | 3,011.15 | 1,577.96 | 1,813.04 | 4,907.26 | 4,407.54 | 4,241.18 |
| Dividend Payout % | 2% | 2% | 2% | 2% | 2% | 2% | 3% | 5% | 10% | 10% | 4% | 5% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -23.82% | -0.09% | 25.82% | -10.26% | -47.61% | 14.95% | 170.61% | -10.19% |
| Change in YoY Net Profit Growth (%) | 0.00% | 23.73% | 25.91% | -36.08% | -37.35% | 62.56% | 155.66% | -180.80% |
MRF Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 6% |
| 3 Years: | 50% |
| TTM: | -13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 21% |
| 3 Years: | 21% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | 10% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 11:20 am
Balance Sheet
Last Updated: May 13, 2025, 3:04 pm
| Month | Sep 2013 | Sep 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 3,651 | 4,535 | 7,220 | 8,637 | 9,734 | 10,833 | 12,210 | 13,409 | 14,028 | 14,703 | 16,699 | 18,484 |
| Borrowings | 1,599 | 1,903 | 2,464 | 2,333 | 2,163 | 2,506 | 1,854 | 2,388 | 3,229 | 3,014 | 2,822 | 3,771 |
| Other Liabilities | 3,023 | 3,391 | 3,566 | 4,075 | 4,577 | 5,098 | 5,373 | 6,780 | 5,799 | 6,648 | 7,325 | 7,307 |
| Total Liabilities | 8,278 | 9,833 | 13,254 | 15,048 | 16,478 | 18,441 | 19,442 | 22,582 | 23,060 | 24,369 | 26,849 | 29,567 |
| Fixed Assets | 2,974 | 3,436 | 4,608 | 5,502 | 6,092 | 6,786 | 8,870 | 9,441 | 9,522 | 10,118 | 12,046 | 13,221 |
| CWIP | 359 | 628 | 1,059 | 848 | 1,079 | 1,403 | 1,741 | 1,002 | 1,233 | 3,046 | 2,385 | 1,169 |
| Investments | 904 | 1,081 | 3,138 | 3,382 | 4,145 | 3,855 | 1,519 | 5,874 | 3,656 | 3,085 | 3,383 | 4,548 |
| Other Assets | 4,041 | 4,688 | 4,448 | 5,316 | 5,162 | 6,397 | 7,312 | 6,265 | 8,648 | 8,120 | 9,036 | 10,629 |
| Total Assets | 8,278 | 9,833 | 13,254 | 15,048 | 16,478 | 18,441 | 19,442 | 22,582 | 23,060 | 24,369 | 26,849 | 29,567 |
Below is a detailed analysis of the balance sheet data for MRF Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
- For Reserves, as of Mar 2025, the value is 18,484.00 Cr.. The value appears strong and on an upward trend. It has increased from 16,699.00 Cr. (Mar 2024) to 18,484.00 Cr., marking an increase of 1,785.00 Cr..
- For Borrowings, as of Mar 2025, the value is 3,771.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,822.00 Cr. (Mar 2024) to 3,771.00 Cr., marking an increase of 949.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7,307.00 Cr.. The value appears to be improving (decreasing). It has decreased from 7,325.00 Cr. (Mar 2024) to 7,307.00 Cr., marking a decrease of 18.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 29,567.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26,849.00 Cr. (Mar 2024) to 29,567.00 Cr., marking an increase of 2,718.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 13,221.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,046.00 Cr. (Mar 2024) to 13,221.00 Cr., marking an increase of 1,175.00 Cr..
- For CWIP, as of Mar 2025, the value is 1,169.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,385.00 Cr. (Mar 2024) to 1,169.00 Cr., marking a decrease of 1,216.00 Cr..
- For Investments, as of Mar 2025, the value is 4,548.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,383.00 Cr. (Mar 2024) to 4,548.00 Cr., marking an increase of 1,165.00 Cr..
- For Other Assets, as of Mar 2025, the value is 10,629.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,036.00 Cr. (Mar 2024) to 10,629.00 Cr., marking an increase of 1,593.00 Cr..
- For Total Assets, as of Mar 2025, the value is 29,567.00 Cr.. The value appears strong and on an upward trend. It has increased from 26,849.00 Cr. (Mar 2024) to 29,567.00 Cr., marking an increase of 2,718.00 Cr..
Notably, the Reserves (18,484.00 Cr.) exceed the Borrowings (3,771.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2016n n 18m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2013 | Sep 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 4.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | -1.00 | -1.00 | 2.00 | 1.00 | 0.00 | 0.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Sep 2013 | Sep 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46 | 47 | 33 | 54 | 52 | 54 | 52 | 48 | 44 | 40 | 42 | 44 |
| Inventory Days | 83 | 79 | 62 | 118 | 88 | 113 | 110 | 115 | 120 | 98 | 108 | 115 |
| Days Payable | 47 | 50 | 36 | 69 | 63 | 64 | 72 | 129 | 60 | 58 | 64 | 57 |
| Cash Conversion Cycle | 83 | 76 | 58 | 103 | 78 | 102 | 90 | 34 | 104 | 80 | 86 | 101 |
| Working Capital Days | 36 | 30 | 1 | 4 | -1 | 2 | 5 | -41 | 10 | -8 | 3 | 8 |
| ROCE % | 29% | 27% | 49% | 23% | 17% | 15% | 13% | 14% | 6% | 7% | 17% | 14% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Equity Hybrid Fund | 210,000 | 3.82 | 2345.34 | 210,000 | 2025-04-22 15:16:47 | 0% |
| Kotak Emerging Equity Fund - Regular Plan | 36,140 | 1.1 | 403.62 | 36,140 | 2025-04-22 16:18:18 | 0% |
| Kotak Flexicap Fund - Regular Plan | 33,000 | 0.89 | 368.55 | 33,000 | 2025-04-22 14:53:35 | 0% |
| Aditya Birla Sun Life India GenNext Fund | 3,376 | 0.86 | 37.7 | 3,376 | 2025-04-22 16:18:18 | 0% |
| Kotak Equity Arbitrage Fund - Regular Plan | 3,350 | 0.12 | 37.41 | 3,350 | 2025-04-22 16:18:18 | 0% |
| SBI Infrastructure Fund | 2,300 | 1.62 | 25.69 | 2,300 | 2025-04-22 16:18:18 | 0% |
| Tata Ethical Fund - Regular Plan | 1,950 | 1.07 | 21.78 | 1,950 | 2025-04-22 16:18:18 | 0% |
| Axis Quant Fund | 1,531 | 1.76 | 17.1 | 1,531 | 2025-04-22 16:18:18 | 0% |
| Invesco India Arbitrage Fund | 1,400 | 0.15 | 15.64 | 1,400 | 2025-04-22 16:18:18 | 0% |
| Aditya Birla Sun Life Midcap Fund | 1,323 | 0.32 | 14.78 | 1,323 | 2025-04-22 16:18:18 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4407.51 | 4907.24 | 1813.10 | 1577.97 | 3011.14 |
| Diluted EPS (Rs.) | 4407.51 | 4907.24 | 1813.10 | 1577.97 | 3011.14 |
| Cash EPS (Rs.) | 8308.58 | 8281.13 | 4768.89 | 4420.49 | 5702.45 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 43604.86 | 39394.25 | 34688.25 | 33094.10 | 31636.34 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 43604.86 | 39394.25 | 34688.25 | 33094.10 | 31636.34 |
| Revenue From Operations / Share (Rs.) | 66399.01 | 59361.34 | 54265.33 | 45558.30 | 38120.73 |
| PBDIT / Share (Rs.) | 10595.71 | 10779.25 | 6230.64 | 5582.03 | 7434.62 |
| PBIT / Share (Rs.) | 6695.82 | 7406.67 | 3275.33 | 2739.93 | 4744.13 |
| PBT / Share (Rs.) | 5846.70 | 6574.10 | 2522.97 | 2141.34 | 4096.32 |
| Net Profit / Share (Rs.) | 4408.70 | 4908.56 | 1813.58 | 1578.40 | 3011.96 |
| NP After MI And SOA / Share (Rs.) | 4408.68 | 4908.54 | 1813.56 | 1578.37 | 3011.93 |
| PBDIT Margin (%) | 15.95 | 18.15 | 11.48 | 12.25 | 19.50 |
| PBIT Margin (%) | 10.08 | 12.47 | 6.03 | 6.01 | 12.44 |
| PBT Margin (%) | 8.80 | 11.07 | 4.64 | 4.70 | 10.74 |
| Net Profit Margin (%) | 6.63 | 8.26 | 3.34 | 3.46 | 7.90 |
| NP After MI And SOA Margin (%) | 6.63 | 8.26 | 3.34 | 3.46 | 7.90 |
| Return on Networth / Equity (%) | 10.11 | 12.46 | 5.22 | 4.76 | 9.52 |
| Return on Capital Employeed (%) | 13.77 | 16.40 | 8.23 | 7.21 | 13.13 |
| Return On Assets (%) | 6.32 | 7.75 | 3.15 | 2.90 | 5.65 |
| Long Term Debt / Equity (X) | 0.02 | 0.04 | 0.05 | 0.05 | 0.06 |
| Total Debt / Equity (X) | 0.15 | 0.12 | 0.16 | 0.20 | 0.12 |
| Asset Turnover Ratio (%) | 0.99 | 0.98 | 0.97 | 0.83 | 0.76 |
| Current Ratio (X) | 1.50 | 1.37 | 1.23 | 1.46 | 1.43 |
| Quick Ratio (X) | 0.86 | 0.78 | 0.68 | 0.87 | 1.02 |
| Inventory Turnover Ratio (X) | 5.58 | 3.54 | 3.81 | 3.79 | 3.06 |
| Dividend Payout Ratio (NP) (%) | 4.53 | 3.56 | 8.27 | 9.50 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 2.40 | 2.11 | 3.14 | 3.39 | 0.00 |
| Earning Retention Ratio (%) | 95.47 | 96.44 | 91.73 | 90.50 | 0.00 |
| Cash Earning Retention Ratio (%) | 97.60 | 97.89 | 96.86 | 96.61 | 0.00 |
| Interest Coverage Ratio (X) | 12.48 | 12.95 | 8.28 | 9.33 | 11.48 |
| Interest Coverage Ratio (Post Tax) (X) | 6.19 | 6.90 | 3.41 | 3.64 | 5.65 |
| Enterprise Value (Cr.) | 50270.95 | 58246.54 | 37807.08 | 30186.42 | 36418.65 |
| EV / Net Operating Revenue (X) | 1.79 | 2.31 | 1.64 | 1.56 | 2.25 |
| EV / EBITDA (X) | 11.19 | 12.74 | 14.31 | 12.75 | 11.55 |
| MarketCap / Net Operating Revenue (X) | 1.70 | 2.25 | 1.55 | 1.43 | 2.16 |
| Retention Ratios (%) | 95.46 | 96.43 | 91.72 | 90.49 | 0.00 |
| Price / BV (X) | 2.58 | 3.38 | 2.42 | 1.96 | 2.60 |
| Price / Net Operating Revenue (X) | 1.70 | 2.25 | 1.55 | 1.43 | 2.16 |
| EarningsYield | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 |
After reviewing the key financial ratios for MRF Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4,407.51. This value is within the healthy range. It has decreased from 4,907.24 (Mar 24) to 4,407.51, marking a decrease of 499.73.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4,407.51. This value is within the healthy range. It has decreased from 4,907.24 (Mar 24) to 4,407.51, marking a decrease of 499.73.
- For Cash EPS (Rs.), as of Mar 25, the value is 8,308.58. This value is within the healthy range. It has increased from 8,281.13 (Mar 24) to 8,308.58, marking an increase of 27.45.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43,604.86. It has increased from 39,394.25 (Mar 24) to 43,604.86, marking an increase of 4,210.61.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43,604.86. It has increased from 39,394.25 (Mar 24) to 43,604.86, marking an increase of 4,210.61.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 66,399.01. It has increased from 59,361.34 (Mar 24) to 66,399.01, marking an increase of 7,037.67.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 10,595.71. This value is within the healthy range. It has decreased from 10,779.25 (Mar 24) to 10,595.71, marking a decrease of 183.54.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6,695.82. This value is within the healthy range. It has decreased from 7,406.67 (Mar 24) to 6,695.82, marking a decrease of 710.85.
- For PBT / Share (Rs.), as of Mar 25, the value is 5,846.70. This value is within the healthy range. It has decreased from 6,574.10 (Mar 24) to 5,846.70, marking a decrease of 727.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4,408.70. This value is within the healthy range. It has decreased from 4,908.56 (Mar 24) to 4,408.70, marking a decrease of 499.86.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4,408.68. This value is within the healthy range. It has decreased from 4,908.54 (Mar 24) to 4,408.68, marking a decrease of 499.86.
- For PBDIT Margin (%), as of Mar 25, the value is 15.95. This value is within the healthy range. It has decreased from 18.15 (Mar 24) to 15.95, marking a decrease of 2.20.
- For PBIT Margin (%), as of Mar 25, the value is 10.08. This value is within the healthy range. It has decreased from 12.47 (Mar 24) to 10.08, marking a decrease of 2.39.
- For PBT Margin (%), as of Mar 25, the value is 8.80. This value is below the healthy minimum of 10. It has decreased from 11.07 (Mar 24) to 8.80, marking a decrease of 2.27.
- For Net Profit Margin (%), as of Mar 25, the value is 6.63. This value is within the healthy range. It has decreased from 8.26 (Mar 24) to 6.63, marking a decrease of 1.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.63. This value is below the healthy minimum of 8. It has decreased from 8.26 (Mar 24) to 6.63, marking a decrease of 1.63.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.11. This value is below the healthy minimum of 15. It has decreased from 12.46 (Mar 24) to 10.11, marking a decrease of 2.35.
- For Return on Capital Employeed (%), as of Mar 25, the value is 13.77. This value is within the healthy range. It has decreased from 16.40 (Mar 24) to 13.77, marking a decrease of 2.63.
- For Return On Assets (%), as of Mar 25, the value is 6.32. This value is within the healthy range. It has decreased from 7.75 (Mar 24) to 6.32, marking a decrease of 1.43.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.15. This value is within the healthy range. It has increased from 0.12 (Mar 24) to 0.15, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. It has increased from 0.98 (Mar 24) to 0.99, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.37 (Mar 24) to 1.50, marking an increase of 0.13.
- For Quick Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.78 (Mar 24) to 0.86, marking an increase of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.58. This value is within the healthy range. It has increased from 3.54 (Mar 24) to 5.58, marking an increase of 2.04.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 20. It has increased from 3.56 (Mar 24) to 4.53, marking an increase of 0.97.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.40. This value is below the healthy minimum of 20. It has increased from 2.11 (Mar 24) to 2.40, marking an increase of 0.29.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.47. This value exceeds the healthy maximum of 70. It has decreased from 96.44 (Mar 24) to 95.47, marking a decrease of 0.97.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.60. This value exceeds the healthy maximum of 70. It has decreased from 97.89 (Mar 24) to 97.60, marking a decrease of 0.29.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 12.48. This value is within the healthy range. It has decreased from 12.95 (Mar 24) to 12.48, marking a decrease of 0.47.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.19. This value is within the healthy range. It has decreased from 6.90 (Mar 24) to 6.19, marking a decrease of 0.71.
- For Enterprise Value (Cr.), as of Mar 25, the value is 50,270.95. It has decreased from 58,246.54 (Mar 24) to 50,270.95, marking a decrease of 7,975.59.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.79. This value is within the healthy range. It has decreased from 2.31 (Mar 24) to 1.79, marking a decrease of 0.52.
- For EV / EBITDA (X), as of Mar 25, the value is 11.19. This value is within the healthy range. It has decreased from 12.74 (Mar 24) to 11.19, marking a decrease of 1.55.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.70, marking a decrease of 0.55.
- For Retention Ratios (%), as of Mar 25, the value is 95.46. This value exceeds the healthy maximum of 70. It has decreased from 96.43 (Mar 24) to 95.46, marking a decrease of 0.97.
- For Price / BV (X), as of Mar 25, the value is 2.58. This value is within the healthy range. It has decreased from 3.38 (Mar 24) to 2.58, marking a decrease of 0.80.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.70, marking a decrease of 0.55.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in MRF Ltd:
- Net Profit Margin: 6.63%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 13.77% (Industry Average ROCE: 31.55%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.11% (Industry Average ROE: 10.6%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.86
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 36.8 (Industry average Stock P/E: 36.8)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.15
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.63%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Tyres & Tubes | No. 114, Greams Road, Chennai (Madras) Tamil Nadu 600006 | mrfshare@mrfmail.com http://www.mrftyres.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. K M Mammen | Chairman & Managing Director |
| Mr. Arun Mammen | Vice Chairman & Mng.Director |
| Mr. Rahul Mammen Mappillai | Managing Director |
| Mr. Samir Thariyan Mappillai | Whole Time Director |
| Mr. Varun Mammen | Whole Time Director |
| Dr. Cibi Mammen | Director |
| Mrs. Ambika Mammen | Director |
| Mrs. Vimla Abraham | Director |
| Mr. Ramesh Rangarajan | Director |
| Mr. Dinshaw Keku Parakh | Director |
| Mr. Arun Vasu | Director |
| Mr. Vikram Chesetty | Director |
| Mr. Prasad Oommen | Director |
| Mr. Vikram Taranath Hosangady | Director |
FAQ
What is the intrinsic value of MRF Ltd?
MRF Ltd's intrinsic value (as of 19 October 2025) is 137664.22 which is 11.72% lower the current market price of 155,940.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 66,136 Cr. market cap, FY2025-2026 high/low of 1,60,150/1,00,500, reserves of ₹18,484 Cr, and liabilities of 29,567 Cr.
What is the Market Cap of MRF Ltd?
The Market Cap of MRF Ltd is 66,136 Cr..
What is the current Stock Price of MRF Ltd as on 19 October 2025?
The current stock price of MRF Ltd as on 19 October 2025 is 1,55,940.
What is the High / Low of MRF Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of MRF Ltd stocks is 1,60,150/1,00,500.
What is the Stock P/E of MRF Ltd?
The Stock P/E of MRF Ltd is 36.8.
What is the Book Value of MRF Ltd?
The Book Value of MRF Ltd is 43,594.
What is the Dividend Yield of MRF Ltd?
The Dividend Yield of MRF Ltd is 0.15 %.
What is the ROCE of MRF Ltd?
The ROCE of MRF Ltd is 13.6 %.
What is the ROE of MRF Ltd?
The ROE of MRF Ltd is 10.6 %.
What is the Face Value of MRF Ltd?
The Face Value of MRF Ltd is 10.0.